TNF and metabolic dysfunction-associated steatotic liver disease: It seems that CD8 + PD1 + -T-cells contribute to the pathophysiology of MASLD, and interestingly, anti-PD1 therapy promotes adverse tumor necrosis factor-alpha (TNFα)-secretion by these cells in the MASLD setting [81].